Topline results from the Phase 2 VISTA trial show that PIPE-307 did not meet its primary or secondary efficacy endpoints
Desai is currently serving the company as Group Finance Controller
The company says the innovation delivers stronger moisture protection for highly sensitive drug molecules
The partnership will enable rapid and reliable product delivery
Winlevi is authorized in EU for the treatment of acne vulgaris
Tofacitinib extended-release tablets are a Janus kinase inhibitor indicated for Rheumatoid Arthritis
The approvals target adult MIBC patients who are ineligible for cisplatin-based chemotherapy
The multibillion-dollar Maryland expansion is part of AstraZeneca’s sweeping $50 billion global investment plan
Subscribe To Our Newsletter & Stay Updated